isoxazoles has been researched along with Neointima in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duthie, KM; Hadoke, PW; Ivy, JR; Kirkby, NS; Lim, WG; McShane, JF; Miller, E; Webb, DJ | 1 |
| Cai, M; Chen, J; Cheng, X; Du, G; Mei, FC; Robichaux, WG; Wang, H; Wang, Z | 1 |
2 other study(ies) available for isoxazoles and Neointima
| Article | Year |
|---|---|
Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury.
Topics: Animals; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Femoral Artery; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth, Vascular; Myography; Neointima; Pyrrolidines; Thiophenes | 2015 |
Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury.
Topics: Animals; Carotid Arteries; Carotid Artery Injuries; Guanine Nucleotide Exchange Factors; Hydrazones; Isoxazoles; Mice; Mice, Knockout; Mitochondrial Dynamics; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima | 2016 |